These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25611231)

  • 1. Tumor relapse after thoracic surgery?
    Garcia ME; Tomasini P; Thomas P; Greillier L; Barlesi F
    J Thorac Oncol; 2015 Feb; 10(2):397-8. PubMed ID: 25611231
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of recurrence after complete resection in patients with NSCLC.
    Uramoto H; Tanaka F
    Anticancer Res; 2012 Sep; 32(9):3953-60. PubMed ID: 22993343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse.
    Sawabata N
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):610-1; author reply 611. PubMed ID: 12928675
    [No Abstract]   [Full Text] [Related]  

  • 4. Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors.
    Kilic A; Landreneau RJ; Luketich JD; Pennathur A; Schuchert MJ
    J Surg Res; 2011 May; 167(2):207-10. PubMed ID: 19896677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival.
    Pirro M; Cagini L; Paciullo F; Pecoriello R; Mannarino MR; Bagaglia F; Capozzi R; Puma F; Mannarino E
    Eur J Cardiothorac Surg; 2013 Oct; 44(4):e245-52. PubMed ID: 23882070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Commentary.
    Shrager J
    Ann Thorac Surg; 2016 Jun; 101(6):2146-7. PubMed ID: 27211933
    [No Abstract]   [Full Text] [Related]  

  • 7. Thoracic wall prosthesis prevents deep invasion by non-small-cell lung cancer.
    Mentens Y; Schrijvers D; Van den Brande J; Van Schil P; Vermorken JB
    Am J Clin Oncol; 2000 Feb; 23(1):32-3. PubMed ID: 10683071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "cured" lung cancer patient: is follow-up by the surgeon worthwhile?
    Hiebert CA
    Ann Thorac Surg; 1995 Dec; 60(6):1557-8. PubMed ID: 8787442
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes after surgical resection of subcentimeter non-small cell lung cancer.
    Schuchert MJ; Kilic A; Pennathur A; Nason KS; Wilson DO; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2011 Jun; 91(6):1681-7; discussion 1687-8. PubMed ID: 21536253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery for thoracic malignancies.
    Cesaretti JA; Pennathur A; Rosenstein BS; Swanson SJ; Fernando HC
    Ann Thorac Surg; 2008 Feb; 85(2):S785-91. PubMed ID: 18222218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobectomy versus limited resection in T1N0 lung cancer.
    Detterbeck FC
    Ann Thorac Surg; 2013 Aug; 96(2):742-4. PubMed ID: 23910135
    [No Abstract]   [Full Text] [Related]  

  • 16. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
    Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different approaches for management of apical invasive lung cancers.
    Niwa H; Masoka A
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):389-92. PubMed ID: 8041194
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postoperative recurrence of the patients with the stage I, II non small cell lung cancer].
    Iwamoto I; Shibata K; Yoshioka M; Matsuzaki Y; Yamamoto T; Edagawa M; Kubota I; Tsuneyoshi A; Koga Y
    Kyobu Geka; 1990 Apr; 43(4):267-70. PubMed ID: 2161967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.
    Yano T; Haro A; Yoshida T; Morodomi Y; Ito K; Shikada Y; Shoji F; Maruyama R; Maehara Y
    J Surg Oncol; 2010 Dec; 102(7):852-5. PubMed ID: 20886558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.